# Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia

> **NCT01826045** · PHASE2 · COMPLETED · sponsor: **BioLeaders Corporation** · enrollment: 200 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DRUG:** Poly-gamma Glutamic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01826045
- **Lead sponsor:** BioLeaders Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01826045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01826045, "Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01826045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*